NASDAQ:MASI

Masimo (MASI) Stock Forecast, Price & News

$86.65

-1.03 (-1.17%)

(As of 12:51 PM ET)

Compare

Today's Range: $86.28
▼
$88.28
50-Day Range: $84.17
▼
$123.24
52-Week Range: $83.03
▼
$198.00

Volume: 223,893 shs
Average Volume: 619,804 shs
Market Capitalization: $4.58 billion

P/E Ratio: 40.49
Dividend Yield: N/A
Price Target: $141.57

Masimo MarketRank™ Forecast

Analyst Rating: Moderate Buy
2.57 Rating Score
Upside/Downside: 60.5% Upside
$141.57 Price Target
Short Interest: Bearish
7.94% of Float Sold Short
Dividend Strength: N/A
Sustainability: -0.86
Upright™ Environmental Score
News Sentiment: 0.54
Based on 10 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: 13.04%
From $3.45 to $3.90 Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.53 out of 5 stars

Medical Sector

157th out of 969 stocks

Electromedical Equipment Industry

4th out of 20 stocks

3.3

Analyst's Opinion

Consensus Rating
Masimo has received a consensus rating of Moderate Buy. The company's average rating score is 2.57, and is based on 4 buy ratings, 3 hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $141.57, Masimo has a forecasted upside of 60.5% from its current price of $88.21.
Amount of Analyst Coverage
Masimo has only been the subject of 4 research reports in the past 90 days.

2.0

Short Interest

Percentage of Shares Shorted
7.94% of the float of Masimo has been sold short.
Short Interest Ratio / Days to Cover
Masimo has a short interest ratio ("days to cover") of 3.9, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in Masimo has recently increased by 11.40%, indicating that investor sentiment is decreasing significantly.

0.0

Dividend Strength

Dividend Yield
Masimo does not currently pay a dividend.
Dividend Growth
Masimo does not have a long track record of dividend growth.

4.2

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
Masimo has received a 61.97% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is driven by its "ECG monitors" product. See details.
Environmental Sustainability
The Environmental Impact score for Masimo is -0.86.

2.5

News and Social Media Coverage

News Sentiment
Masimo has a news sentiment score of 0.54. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.69 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 10 news articles for Masimo this week, compared to 7 articles on an average week.
Search Interest
Only 8 people have searched for MASI on MarketBeat in the last 30 days. This is a decrease of -27% compared to the previous 30 days.
MarketBeat Follows
7 people have added Masimo to their MarketBeat watchlist in the last 30 days. This is an increase of 75% compared to the previous 30 days.

1.7

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Masimo insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 9.70% of the stock of Masimo is held by insiders.
Percentage Held by Institutions
85.96% of the stock of Masimo is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

2.5

Earnings and Valuation

Earnings Growth
Earnings for Masimo are expected to grow by 13.04% in the coming year, from $3.45 to $3.90 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Masimo is 41.22, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 108.38.
Price to Earnings Ratio vs. Sector
The P/E ratio of Masimo is 41.22, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 91.36.
Price to Book Value per Share Ratio
Masimo has a P/B Ratio of 3.47. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Masimo (NASDAQ:MASI) Stock

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and O3 regional oximetry. It also provides brain function and hemodynamic monitoring solutions; patient position and activity tracking, and neuromodulation technology solutions; and Masimo Hospital Automation platform, including hospital automation solutions, including Patient SafetyNet, Patient SafetyNet Surveillance, SafetyNet, SafetyNet-Open, Replica, Iris, MyView, UniView, Uniview: 60, Trace, Masimo Sleep, Centroid, and Bridg; and nasal high-flow ventilation, neuromodulation therapeutics, and telehealth solutions. It provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers; and home wellness products through e-commerce internet sites, such as masimopersonalhealth.com, amazon.com, and shopify.com. Masimo Corporation was incorporated in 1989 and is headquartered in Irvine, California.

MASI Price History

30 days | 90 days | 365 days | Advanced Chart

MASI Stock News Headlines

September 30, 2023 | markets.businessinsider.com

Masimo Investor Deadline Approaching

September 30, 2023 | americanbankingnews.com

Masimo (NASDAQ:MASI) Hits New 1-Year Low at $83.03

October 2, 2023 | PressReach (Ad)

Nuclear Revival Creates Opportunities for Uranium

Uranium companies set to benefit from increased demand for clean energy.

September 27, 2023 | finance.yahoo.com

Unveiling Masimo (MASI)'s Value: Is It Really Priced Right? A Comprehensive Guide

September 27, 2023 | americanbankingnews.com

Masimo (NASDAQ:MASI) Upgraded to "Hold" at StockNews.com

September 26, 2023 | americanbankingnews.com

Stock Traders Buy Large Volume of Call Options on Masimo (NASDAQ:MASI)

September 25, 2023 | msn.com

Masimo: Lots Of Questions

September 24, 2023 | americanbankingnews.com

Masimo (NASDAQ:MASI) Sets New 12-Month Low at $96.66

October 2, 2023 | PressReach (Ad)

Nuclear Revival Creates Opportunities for Uranium

Uranium companies set to benefit from increased demand for clean energy.

September 22, 2023 | markets.businessinsider.com

Masimo Ongoing Deadline Alert

September 22, 2023 | theglobeandmail.com

ROSEN, A LEADING NATIONAL FIRM, Encourages Masimo Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - MASI

September 22, 2023 | americanbankingnews.com

Masimo Co. (NASDAQ:MASI) Expected to Post Q3 2024 Earnings of $0.86 Per Share

September 14, 2023 | msn.com

Activist investor Politan Capital increases ownership in Azenta -filing

September 12, 2023 | reuters.com

US court upholds rulings for Apple in Masimo smartwatch patent fight

September 12, 2023 | benzinga.com

ROSEN, A LEADING LAW FIRM, Encourages Masimo Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – MASI

September 12, 2023 | barrons.com

Masimo Corp.

September 12, 2023 | benzinga.com

ROSEN, NATIONAL TRIAL LAWYERS, Encourages Masimo Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - MASI

September 11, 2023 | markets.businessinsider.com

SHAREHOLDER ALERT: Potential Recovery for Masimo Corporation (MASI) Investors Affected by Stock Drop - Levi & Korsinsky Pursuing Class Action Lawsuit

September 8, 2023 | benzinga.com

MASI Investors Have Opportunity to Lead Masimo Corporation Securities Fraud Lawsuit

September 8, 2023 | benzinga.com

Shift4 Payments, Masimo Corporation, and NAPCO Security Class Action Update: Johnson Fistel Alerts Shareholders of Ongoing Legal Proceedings

September 7, 2023 | finance.yahoo.com

Masimo to Present in Wells Fargo Healthcare Conference

September 7, 2023 | stockhouse.com

SHAREHOLDER ACTION NOTICE: The Schall Law Firm Encourages Investors in Masimo Corporation with Losses of $100,000 to Contact the Firm

September 6, 2023 | benzinga.com

MASI Stockholders Should Contact Robbins LLP for Information About the Class Action Involving Masimo Corporation

September 6, 2023 | finanznachrichten.de

DEADLINE ACTION NOTICE: The Schall Law Firm Encourages Investors in Masimo Corporation with Losses of $100,000 to Contact the Firm

September 5, 2023 | benzinga.com

SHAREHOLDER ALERT: Levi & Korsinsky Notifies Masimo Corporation (MASI) Investors of a Class Action Lawsuit and Upcoming Deadline

September 2, 2023 | prnewswire.com

TOP RANKED ROSEN LAW FIRM Encourages Masimo Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - MASI

September 1, 2023 | finance.yahoo.com

Masimo's (MASI) Inks Agreement to Improve Patient Outcomes

See More Headlines

Receive MASI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Masimo and its competitors with MarketBeat's FREE daily newsletter.

MASI Company Calendar

Last Earnings: 8/08/2023
Today: 10/02/2023
Next Earnings (Estimated): 11/14/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Electromedical equipment
Sub-Industry: Health Care Equipment
Sector: Medical
Current Symbol: NASDAQ:MASI
CUSIP: 57479510
CIK: 937556
Web: www.masimo.com
Phone: (949) 297-7000
Fax: 949-297-7001
Employees: 6,000
Year Founded: 1989

Price Target and Rating

Average Stock Price Forecast: $141.57
High Stock Price Forecast: $180.00
Low Stock Price Forecast: $110.00
Forecasted Upside/Downside: +61.5%
Consensus Rating: Moderate Buy
Rating Score (0-4): 2.57
Research Coverage: 7 Analysts

Profitability

EPS (Most Recent Fiscal Year): $2.14
Trailing P/E Ratio: 40.97
Forward P/E Ratio: 25.41
P/E Growth: N/A
Net Income: $143.50 million
Net Margins: 5.30%
Pretax Margin: 7.26%
Return on Equity: 15.79%
Return on Assets: 6.66%

Debt

Debt-to-Equity Ratio: 0.68
Current Ratio: 2.11
Quick Ratio: 1.16

Sales & Book Value

Annual Sales: $2.19 billion
Price / Sales: 2.12
Cash Flow: $7.43 per share
Price / Cash Flow: 11.80
Book Value: $25.45 per share
Price / Book: 3.45

Miscellaneous

Outstanding Shares: 52,818,000
Free Float: 47,695,000
Market Cap: $4.63 billion
Optionable: Optionable
Beta: 0.81

Social Links

Investing Strategies To Help Grow Your Retirement Income

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Key Executives

Mr. Joseph E. Kiani (Age 58)
Founder, CEO & Chairman
Comp: $3.31M

Mr. Micah Young (Age 44)
Exec. VP & CFO
Comp: $1.13M

Mr. Bilal Muhsin (Age 42)
Chief Operating Officer
Comp: $1.2M

Mr. Thomas Samuel McClenahan (Age 50)
Exec. VP, Gen. Counsel & Corp. Sec.
Comp: $957.51k

Mr. Tao Leopold Levy (Age 49)
Exec. VP of Bus. Devel.
Comp: $798.52k

Mr. Paul Hataishi (Age 48)
Sr. VP & Chief Accounting Officer

Mr. Yongsam Lee (Age 58)
Exec. VP & Chief Information Officer

Dr. Steven J. Barker (Age 78)
Chairman of Scientific Advisory Board & Chief Science Officer

Mr. Eli Kammerman
VP of Bus. Devel. & Investor Relations

Mr. Jon Coleman (Age 59)
Pres of Worldwide Sales, Professional Services & Medical Affairs

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

MASI Stock - Frequently Asked Questions

Should I buy or sell Masimo stock right now?: 7 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Masimo in the last year. There are currently 3 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" MASI shares.
View MASI analyst ratings or view top-rated stocks.
What is Masimo's stock price forecast for 2023?: 7 Wall Street analysts have issued 12 month price targets for Masimo's shares. Their MASI share price forecasts range from $110.00 to $180.00. On average, they expect the company's stock price to reach $141.57 in the next twelve months. This suggests a possible upside of 61.5% from the stock's current price.
View analysts price targets for MASI or view top-rated stocks among Wall Street analysts.
How have MASI shares performed in 2023?: Masimo's stock was trading at $147.95 on January 1st, 2023. Since then, MASI stock has decreased by 40.7% and is now trading at $87.68.
View the best growth stocks for 2023 here.
When is Masimo's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Tuesday, November 14th 2023.
View our MASI earnings forecast.
How were Masimo's earnings last quarter?: Masimo Co. (NASDAQ:MASI) released its quarterly earnings results on Tuesday, August, 8th. The medical equipment provider reported $0.62 EPS for the quarter, missing analysts' consensus estimates of $0.86 by $0.24. The medical equipment provider earned $455.30 million during the quarter, compared to analyst estimates of $478.27 million. Masimo had a net margin of 5.30% and a trailing twelve-month return on equity of 15.79%. The business's revenue was down 19.5% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.35 EPS.
What ETFs hold Masimo's stock?: ETFs with the largest weight of Masimo (NASDAQ:MASI) stock in their portfolio include Harbor Health Care ETF (MEDI), Global X Telemedicine & Digital Health ETF (EDOC), Fidelity Disruptive Medicine ETF (FMED), First Trust Nasdaq Lux Digital Health Solutions ETF (EKG), First Trust Indxx Medical Devices ETF (MDEV), BlackRock Future Health ETF (BMED), SPDR S&P Kensho New Economies Composite ETF (KOMP) and iShares U.S. Medical Devices ETF (IHI).
What guidance has Masimo issued on next quarter's earnings?: Masimo issued an update on its FY 2023 earnings guidance on Tuesday, August, 8th. The company provided earnings per share (EPS) guidance of $3.35-$3.55 for the period, compared to the consensus estimate of $3.71. The company issued revenue guidance of $2.10 billion-$2.20 billion, compared to the consensus revenue estimate of $2.21 billion.

What is Joe E. Kiani's approval rating as Masimo's CEO?: 136 employees have rated Masimo Chief Executive Officer Joe E. Kiani on Glassdoor.com. Joe E. Kiani has an approval rating of 90% among the company's employees.
What other stocks do shareholders of Masimo own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Masimo investors own include NVIDIA (NVDA), Netflix (NFLX), Shopify (SHOP), Okta (OKTA), PayPal (PYPL), Alibaba Group (BABA), Mastercard (MA), Trade Desk (TTD), Walt Disney (DIS) and Twilio (TWLO).
What is Masimo's stock symbol?: Masimo trades on the NASDAQ under the ticker symbol "MASI."
How do I buy shares of Masimo?: Shares of MASI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Masimo's stock price today?: One share of MASI stock can currently be purchased for approximately $87.68.
How much money does Masimo make?: Masimo (NASDAQ:MASI) has a market capitalization of $4.63 billion and generates $2.19 billion in revenue each year. The medical equipment provider earns $143.50 million in net income (profit) each year or $2.14 on an earnings per share basis.
How many employees does Masimo have?: The company employs 6,000 workers across the globe.
How can I contact Masimo?: Masimo's mailing address is 52 DISCOVERY, IRVINE CA, 92618. The official website for the company is www.masimo.com. The medical equipment provider can be reached via phone at (949) 297-7000, via email at ekammerman@masimo.com, or via fax at 949-297-7001.

This page (NASDAQ:MASI) was last updated on 10/2/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial